1 result for "Atai Therapeutics, Inc."
Add this URL to any RSS reader. Updated daily.
Atai Therapeutics US12606525B2 Patent Grant
USPTO granted patent US12606525B2 to Atai Therapeutics, Inc. covering dimethyltryptamine analogues as nitric oxide delivery drugs, specifically compounds of Formula (I) or (II) and pharmaceutical compositions comprising those compounds. The patent was granted on April 21, 2026, with application number 18657306 and 34 claims.
Routine
Rule
Intellectual Property
Get alerts for "Atai Therapeutics, Inc."
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Browse Categories
Agriculture & Food Safety
73
AI Regulation
3
Banking & Finance
414
Consumer Protection
89
Courts & Legal
411
Data Privacy & Cybersecurity
90
Defense & National Security
53
Education
55
Energy
100
Environment
152
Gaming
2
Government & Legislation
431
Healthcare
15
Healthcare & Life Sciences
375
Immigration
10
Insurance
76
Labor & Employment
138
Pharma & Drug Safety
21
Professional Licensing
8
Real Estate & Housing
78
Securities & Markets
154
Tax
78
Telecom & Technology
47
Trade & Sanctions
141
Transportation
91
Get alerts for "Atai Therapeutics, Inc."
We'll email you when new changes match "Atai Therapeutics, Inc.".
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.
You're subscribed!